Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer

Background. Adding taxanes to anthracycline-based adjuvant chemotherapy has shown significant improvement particularly in node-positive patients, but optimal dose and schedule remain undetermined. Objectives. This study aimed to assess the feasibility of dose-dense epirubicin and cyclophosphamide fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirzaei, Hamid Reza, Sabet Rasekh, Parisa, Nasrollahi, Fatemeh, Sabet Rasekh, Parto, Akbari Tirabad, Zahra, Moein, Hamid Reza, Ghaffari Pour, Taban, Hajian, Parastoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800644/
https://www.ncbi.nlm.nih.gov/pubmed/24187626
http://dx.doi.org/10.1155/2013/404396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800644/
https://www.ncbi.nlm.nih.gov/pubmed/24187626
http://dx.doi.org/10.1155/2013/404396

Ejemplares similares